Stay updated on Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedRevision: v3.5.4 appears in the page footer, replacing the previous v3.5.3. This indicates a small update to the site's revision tag within the Record History display.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new Completed status with Study Status and Recruitment Status entries was added, along with corresponding dates, and the prior Active, not recruiting status was removed. This documents that the trial has concluded and is no longer recruiting.SummaryDifference0.2%

- Check30 days agoChange DetectedThe page’s displayed software/site revision was updated from v3.5.0 to v3.5.3, reflecting a minor ClinicalTrials.gov release rather than any change to the underlying study record.SummaryDifference0.0%

- Check66 days agoChange DetectedAdded a new Study Status entry to the record history in the latest revision (v3.5.0). The older Revision: v3.4.3 was removed (2025-08-29).SummaryDifference0.2%

- Check81 days agoChange DetectedAdded a new history entry: Revision: v3.4.3, and removed Revision: v3.4.2.SummaryDifference0.0%

- Check102 days agoChange DetectedA new revision entry v3.4.2 appears in the history, and the previous revision v3.4.1 is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page.